Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-15

Clinical Trial Update: Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial assessing butyphthalide for cognitive outcomes after cerebral vascular events (stroke/PSCI); study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • butyphthalide (butyphthalide)

Snippet

Sponsor: Fudan University | Conditions: Stroke, Post-stroke Cognitive Impairment (PSCI) | Phase 3 | Status: RECRUITING